Xu S, Shi Y, Li S. Enhanced anticancer synergy of LOM612 in combination with selinexor: FOXO1 nuclear translocation-mediated inhibition of Wnt/beta-catenin signaling pathway in breast cancer. Cancer Chemother Pharmacol 2023 Dec 5. doi: 10.1007/s00280-023-04618.
PMID: 38051377